Skip to main content
. 2026 Mar 4;18(5):835. doi: 10.3390/cancers18050835
AUC Area under the curve
BMI Body-mass index
CIPN Chemotherapy-induced peripheral neuropathy
EC Epirubicin/cyclophosphamide
ETC Epirubicin plus paclitaxel plus cyclophosphamide
NPV Negative predictive value
PAC Paclitaxel
Pembro Pembrolizumab
PPV Positive predictive value
ROC Receiver operating characteristic
TCbHP Docetaxel plus carboplatin plus trastuzumab plus pertuzumab
TNS Total Neuropathy Score
UENS Utah Early Neuropathy Scale